8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 1/19
PrintClose
DrugUseduringBreastfeeding
Dateofrevision:December2014
M.S.BrochetBPharmMScS.ItoMDFRCPCThefollowingisanoverviewofdruguseduringbreastfeeding.Thisinformationisnotintendedtobeacomprehensivereviewthereaderisthereforeencouragedtoseekadditionalandconfirmatoryinformation.
PrinciplesofDrugUseduringBreastfeeding
Clinicianscanusethefollowinggeneralprinciplestomanagecaseswheredrugexposureinabreastfedinfantisquestioned:
Almostalldrugsareexcretedtosomedegreeinbreastmilk.Breastmilk/feedinghastangiblemedicalandotherbenefitscomparedtoformula.1,2,3Evenwhenthebreastmilk:maternalplasmaconcentrationratioapproachesorexceeds1,theamountofdrugingestedbytheinfantrarelyattainstherapeuticlevels.Briefexposuretoadrug,asmightbeexpectedinthecaseofanalgesicsgiventorelievepostpartumpain,isusuallyoflessconcernthanadruggivenforlongperiodsoftime.Theamountofdrugingestedbytheinfantcan,onoccasion,beminimizedbyfeedingtheinfantjustbeforeoratthetimeofmaternaldosing.Inthecaseofchronicdrugtherapy,theinfantisusuallyexposedtolowerconcentrationsofthedrugwhilebreastfeedingthanwhilethefetusisinutero.Nevertheless,inmostcasesthelongtermconsequencesofchronicexposuretosubtherapeuticlevelsofmedicationsarenotknown.Recommendationsaboutbreastfeedingduringdrugtherapydependonknowingifsmallamountsofthedrug(subtherapeuticamounts)takenforevenshortperiodsoftimemaybeassociatedwiththefollowing:
idiosyncraticreactions,e.g.,chloramphenicolinterferencewithgeneticallyabnormalmetabolicpathways,e.g.,nitrofurantoininpatientswithG6PDdeficienciessynergisticeffectswithdrugstheinfantreceivestherapeutically,e.g.,caffeineincoffeeandteamayenhanceeffectsoftherapeuticcaffeineoraminophyllineintheneonate
Cliniciansrequireareasonableknowledgeofpharmacologyandtherapeuticsinthenewbornaswellasaknowledgeoftheamountofdrugexcretedinbreastmilk.
TheDrugsandLactationdatabase(LactMed)isareliableandauthoritativewebbasedresourceaboutdrugexcretioninbreastmilkandrecommendationsforbreastfeedingduringmaternaltherapy.5ItisfreeofchargeandrunbytheUSNationalLibraryofMedicine.LactMedishousedwithintheTOXNETWebsite.
Considerseveralimportantquestionswhenabreastfeedingmotherstartsdrugtherapy:4
IsthedrugabsorbedfromtheGItract?Isthedrugevergivendirectlytoinfantsfortherapeuticreasons?Doestheestimateddosedeliveredthroughbreastmilkapproachatherapeuticquantity?Aretheeffectsofthedrugeasilyrecognizedintheinfant?Arethereidiosyncraticorallergicreactionstothedrugthatarenotdoserelated?Aretherelesstoxicalternativesformaternaltherapy?Isthereapotentialfordrugaccumulationduringprolongedtherapy?Couldsubtherapeuticdosesofthedrugmaskearlysignsofmedicalconditionsintheinfant?Istheriskposedbythedrugsubstantialenoughtooutweighthesignificantprovenbenefitsofbreastfeeding?
DrugsCompatiblewithBreastfeeding
Drugsconsideredcompatiblewithbreastfeedingfaroutnumberthoseconsideredcontraindicatedduringbreastfeeding.Table1discussessomeexamplesofdrugsconsideredtobecompatiblewithbreastfeeding.
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 2/19
Table1:DrugsCompatiblewithBreastfeedinga
TherapeuticClass
Drugs/DrugClasses
CompatiblewithBreastfeeding Comments
Analgesics Acetaminophen,morphine
Formostopioidanalgesics,theamountofdrugexcretedinbreastmilkissmall,andshorttermuseshouldbeofnomajorconcern.Ifusedforlongerthan3daysmonitorcloselyfordrowsiness/sedation,difficultybreathing,difficultybreastfeeding,decreasedtone,particularlyinprematureinfantsandneonates.6Meperidineisanexceptioninneonates,thelonghalflivesofmeperidine(13h)andnormeperidine(63h)mayresultinaccumulationinplasma,possiblyleadingtoneurobehaviouraldepression.7,8Inaddition,usecodeinewithcautionatthelowesteffectivedosefortheshortestperiodoftime.MotherswithultrarapidmetabolizerCYP2D6genotype(Chinese,Japanese,Hispanic0.51%Caucasian110%AfricanAmerican3%NorthAfrican,Ethiopian,SaudiArabian1628%)mayexperienceintensifiedeffectsfromaregulardosingregimenofcodeineduetoincreasedconversionofcodeinetomorphine,causingmorphinetoxicity.Resultanthighlevelsofmorphineinmaternalserumcouldcauserelativelyhighmorphinelevelsinbreastmilk.4Mothersexperiencingmorphinetoxicity,whetherduetothisgenotypeormorphineoverdose,shouldnotbreastfeed.Codeineuseshouldbelimitedtolessthan34daysinabreastfeedingmother.OxycodoneandhydrocodonearealsometabolizedbyCYP2D6toapotentactivemetaboliteseecodeineforinformationregardingtheultrarapidmetabolizerCYP2D6genotype.4MaternaloxycodoneusehasbeenassociatedwithasimilarincidenceofneonatalCNSdepressionascodeine9andlevelsinbreastmilkstronglycorrelatedwithplasmalevelsinonestudy.10Useofoxycodoneorhydrocodonewhilebreastfeedingshouldbeconsideredonlyinpatientswhocannottakeotheropioidsandshouldbelimitedtolessthan34days.Theamountofmorphineexcretedinbreastmilkcouldreach7.5%ofthepediatricdose.11Despitewidespreaduseofmorphinebybreastfeedingmothers,thereisonlyonecasereportofanursinginfantwiththerapeuticplasmaconcentrations.12Limiteddataindicatesthathydromorphoneisexcretedintobreastmilkinsmallamounts.4Datafortramadolarelacking.Shorttermusemaybeaconcernduetoitslonghalflife(7hfortramadoland8.5hfortheactivemetaboliteinnewborns)especiallyinprematureinfants:monitorforincreasedsleepiness.Excretionintobreastmilkislow,thereforeitisunlikelytoaffecthealthybabies.Anexclusivelybreastfedinfantwouldreceiveabout10%ofthetherapeuticdoseforachild.13Methadonelevelsinhumanmilkarelow.Anexclusivelybreastfedinfantwouldreceive
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 3/19
Antibiotics Aminoglycosides,cephalosporins,clindamycin,fluoroquinolones,macrolides,metronidazole,nitrofurantoin,penicillins,sulfonamides
Formanyantibiotics,theamountsingestedbyabreastfedinfantwillbebelowtherapeuticlevels(e.g.,penicillins,cephalosporins),butmightbesufficienttoresultinidiosyncraticreactions(e.g.,chloramphenicol)orcauseanemiainaninfantwithG6PDdeficiency(e.g.,nitrofurantoin,sulfonamides).OtherpotentialproblemsaremodificationstothenormalGIfloraleadingtothrushanddiarrhea.However,clinicalsignificanceoftheserisksisusuallynothighenoughtojustifydiscontinuationofbreastfeeding.AminoglycosidesareexcretedinbreastmilkwhenadministeredimorivtothemotherbecausethedrugsarepoorlyabsorbedfromtheGItract,itisunlikelythatrenaltoxicityorototoxicitywouldoccurintheinfant.Onlysmallamountsoforalclindamycinareexcretedinbreastmilk(26%oftherecommendedpediatricdosage).Itisunlikelythatthesequantitieswouldbeclinicallyrelevantbutatleastonecaseofbloodystoolshasbeenreportedinthebreastfedinfantofamotherreceivingclindamycin.Topicalclindamycin(notusedinthenipplearea)isgenerallyassociatedwithlowermaternalsystemicdruglevelsandlowerbreastmilkexcretioncomparedtosystemicuse.14Erythromycinisexcretedinbreastmilkinlowamountsandiscompatiblewithbreastfeeding.Limiteddataregardingclarithromycinandazithromycindemonstratethatthesedrugsareexcretedinbreastmilkinsmallamounts,buttheamountofdrugingestedbyabreastfedinfantislikelybelowtherapeuticpediatriclevels.16,17Nodataareavailableregardingtheexcretionoftelithromycininbreastmilk.Metronidazoleuseduringbreastfeedinghasraisedsomeconcernsbasedonreportsthatitismutagenicinbacteriaandcarcinogenicinrodentsduringlifelongingestion.Specificuntowardeffectsinanursinginfantasaresultofmetronidazoleingestionhavenotbeenreported.Withoutmoredirectevidenceoftheharmfuleffectsofshorttermuseinhumans,itseemsoverlyconservativetowithholdthedrugordiscontinuebreastfeedinginpatientswithsymptomaticinfections.Forthetreatmentoftrichomoniasiswithasingleoraldoseofmetronidazole2g,somecliniciansnowrecommendaninterruptionofbreastfeedingfor1224h,especiallywithyoungbabies.7Topicalmetronidazole(aslongasitisnotusedinthenipplearea)isconsideredcompatiblewithbreastfeedingsincebloodlevelsandexcretionintobreastmilkarelowerthanwithmaternalsystemicmetronidazoleuse.Fluoroquinoloneshavetraditionallynotbeenusedininfantsbecauseofconcernsregardingadverseeffectsonjointdevelopment.Studiesindicatelittlerisk.Shorttermuseofciprofloxacin,levofloxacin,norfloxacinorofloxacinisacceptableinnursingmothers.Thesequinolonesareexcretedinbreastmilkinsmallamountswhichdonotresultinsignificantserumconcentrationsinbreastfedinfants.Thecalciuminbreastmilkmayalsodecreasequinoloneabsorptionintheinfant.14Therearenodataavailableformoxifloxacin.Maternaluseofgatifloxacineyedropspresentsnegligibleriskforthenursinginfant.14Thesulfonamidesareexcretedinbreastmilkinsmallamounts.ThereareconcernsaboutthesedrugscausinganemiainaninfantwithG6PDdeficiencywhichismorecommoninthoseofAfrican,Greek,middleeasternandsoutheastAsianorigin.Usewithcautioninmothersbreastfeedingprematureinfantsorneonateswithhyperbilirubinemia.7Usealternativesunlesstheinfectionisnotrespondingtoothertherapy.Theuseofnitrofurantoininbreastfeedingmothersisgenerallysafe,asonlysmallamountstransferintothebreastmilk.Despitethelackofdocumentedreports,thereisapotentialriskofhemolyticanemiainallnewbornsexposedtonitrofurantoinowingtotheirglutathioneinstability,especiallyininfantswithG6PDdeficiency.Althoughsomesuggestthatnitrofurantoinbeavoided
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 4/19
ininfants
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 5/19
viabreastmilk,butacausativelinkisuncertain.29Therearealsoreportsofuneventfulbreastfeedingduringmaternalsertralineuse.30Paroxetineistransferredintobreastmilkresultinginanestimatedinfantdoseofbetween0.1%and4.3%oftheweightadjustedmaternaldoseb.Inthesestudies,paroxetinewasnotdetectedintheserumofthemajorityofinfants(inwhomitwasmeasured)andnoadverseeffectswerereported.30,31,32,33,34Theamountoffluoxetineexcretedinbreastmilkis218%oftheweightadjustedmaternaldose.b,25,26,27,28,30,31,32,33,34,35Nearlytherapeuticserumconcentrationswerereportedinsomesymptomaticinfants.36,37,38,39,40,41,42,43,44Also,infantsbreastfedbymothersonfluoxetinehadpoorerweightgain,althoughthesignificanceisunclear.40Afewcasesofcolichavebeenassociatedwithfluoxetine.37,41Becauseofthelonghalflivesoffluoxetineanditsactivemetabolites,cautionisadvised,particularlywhenbreastfeedingapreterminfantorneonate.14Excretionoffluvoxamineseemstobelowandnoadverseeffectswerereportedinthefewavailablecases.30,45Theamountofcitalopramexcretedinbreastmilkisapproximately0.79%oftheweightadjustedmaternaldoseb.Inonestudy,asingleinfantpresentedanuneasysleeppatternwhichimprovedwhenmaternaldosewasdecreased.46,47,48,49Theamountofescitalopramexcretedinbreastmilkislessthan8%oftheweightadjustedmaternaldosebandnoadverseeffectswerereportedintheavailablecases.14Venlafaxineanditsmetabolitesareexcretedinbreastmilkinapproximately59%oftheweightadjustedmaternaldose.b,50,51Inonestudyof7infantstheactivemetaboliteOdesmethylvenlafaxinewasdetectedintheplasmaof4infants.Noadverseeffectswerereportedintheinfants.52Excretionofdesvenlafaxine(Odesmethylvenlafaxine)intobreastmilkislessthan7%ofthematernalweightadjusteddosebandserumdruglevelsofbreastfedinfantsarelessthan6%ofsimultaneousmaternallevels.53Althoughbupropion,moclobemideandmirtazapinehavenotbeenstudiedextensively,foreachofthesedrugstheamountexcretedinbreastmilkislessthan2%oftheweightadjustedmaternaldose.bNoadverseeffectswerereported14,54,55,56,57,58,59exceptforbupropion(threecasereportsofpossibleseizure)althoughthesignificanceisunclear.60,61,62Limiteddataindicatethatexcretionoftrazodoneintobreastmilkislow,butdataonitsactivemetabolitesarelacking.63,64,65,66Theamountofduloxetineexcretedintobreastmilkseemstobelow,lessthan1%oftheweightadjustedmaternaldosebisexcretedintobreastmilk.67,68Overall,nosignificantshorttermeffecthasbeenreportedforthecommonlyusedantidepressantssuchastricyclicsandSSRIs.Clinicalsignificanceofreportedadverseeventsremainsunclear.Basethechoiceofantidepressantsonthematernalconditionandresponse.Nomatterwhatdrugisused,usecautionuntilmoreexperienceisgained.
Antiepileptics Carbamazepine,clonazepam,phenytoin,valproicacid
Theexcretionintomilkislow:approximately5%and2%oftheweightadjustedmaternaldosebforcarbamazepineanditsepoxidemetabolite,lessthan4%forvalproicacid,andlessthan8%forphenytoin.Noadverseeffectsduetocarbamazepine,phenytoinorvalproateexposureviabreastmilkwereobservedat
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 6/19
6yearsinaprospectiveobservationalmulticenterstudy.69Limiteddataforclonazepamindicatethattheweightadjustedmaternaldoseis
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 7/19
Antihistamines Cetirizine,desloratadine,fexofenadine,loratadine
Loratadineandfexofenadine(basedonterfenadinedata)resultininfantexposurelevelsof6months.11Theestimatedamountofdiphenhydramineababyisexposedtothroughbreastmilkislow(approximately0.3%ofapediatricdose).Occasionaluseisnotexpectedtocauseadverseeffects.Nonsedatingantihistaminesarepreferredforlongertermuseasanecdotalreportssuggestapossibledecreaseinmilkproduction.14Otherantihistaminesmaybegiven,butdataontheconcentrationsofthesedrugsinbreastmilkarelacking.Infantsshouldbemonitoredforirritabilityordrowsiness.79Antihistaminesarenotusuallycontraindicatedduringbreastfeeding.Alternativestooralantihistaminesthatmaybeconsideredduringbreastfeedingincludenasallyadministeredcorticosteroidsorcromolyn.Cromolynandnedocromileyedropsareconsideredacceptableduringbreastfeedingbecauseoftheirlowbioavailability.7
Antihypertensives Labetalol,metoprolol,propranololBenazepril,captopril,enalapril,quinapril,ramiprilMethyldopaDiltiazem,nifedipine,verapamilHydrochlorothiazide,furosemide
Betablockersthataresafetouseevenintheneonatalperiodarelabetalol,metoprololandpropranolol.70,80,81Acebutolol,atenololandsotalol(althoughthelatterisnotindicatedasanantihypertensiveagent)maycauserelativelyhighexposurelevels,10%,25%and20%,respectively,ofthoseexpectedwhenthedrugisgivendirectlytoaninfantinatherapeuticdose.Thismaynotbeaprobleminpostneonatalinfants.However,exercisecautionintheearlyneonatalperiodbecausenewbornsmayhavelowclearanceofatenololandsotalolasaresultofimmaturerenalfunction(lowGFR).Signsofbetablockadehavebeenreportedinabreastfedinfantofawomantakingatenolol(bradycardia,cyanosis,hypotension,hypothermia)andacebutolol(hypotension,bradycardia,tachypnea,drowsiness).82,83,84MethyldopaandsomeACEinhibitors(benazepril,captopril,enalapril,quinaprilandramipril)arenotexcretedintobreastmilkinclinicallysignificantamountsandareconsideredcompatiblewithbreastfeeding.11,14,85,86DataconcerningtheuseofangiotensinIIreceptorantagonistsduringlactationarelacking.Usewithcautioninbreastfeedingmothers.7Nifedipineisexcretedintobreastmilkinlowamountsandnoadverseeffectshavebeenreportedininfants.Itisconsideredcompatiblewithbreastfeeding.Verylimiteddataindicatesamountsofdiltiazemandverapamilinbreastmilkarelowandwouldnotbeexpectedtohaveanyadverseeffectsinbreastfedinfants.14Dataondiureticsarelacking.Intensediuresismaydecreasebreastmilkproduction.Hydrochlorothiazide50mgdailyisconsideredacceptableduringbreastfeedingbasedonacasereportwhereanexclusivelybreastfedinfantreceived
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 8/19
(prophylactic)
proguanil nursinginfant.7ThereisnoinformationontheamountofprimaquinethatentersintohumanbreastmilkbutthedrugmaycauseseverehemolysisinG6PDdeficientindividuals.Becausedataarenotyetavailableonthesafetyandefficacyofatovaquone/proguanilininfantsweighing
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 9/19
Antivirals Acyclovir,valacyclovir
Acyclovirandvalacyclovir(whichisalmostentirelytransformedtoacyclovir)excretionintomilkarelow(lessthan1%ofthemaximaldailypediatricdosage).Noadverseeffectswerereportedinbreastfedinfants.102Nostudieshavebeenreportedontheexcretionofamantadineinhumanmilk.However,amantadineisadopamineagonist.Clinicalstudiesusingamantadineconcurrentlywithneurolepticmedicationshavedemonstratedadecreaseofprolactinandgalactorrheainducedbyneurolepticdrugs.Thematernalprolactinlevelinamotherwithestablishedlactationmaynotaffectherabilitytobreastfeed.103,104Dataonfamciclovirinbreastfeedingandpediatricsarelacking.Acyclovirandvalacyclovirarepreferred.14
Oseltamivir Sincetheamountofoseltamivirexcretedinbreastmilkseemstobelow(lessthan1%oftheusualpediatricdosageand0.5%oftheweightadjustedmaternaldosebafter75mgtwicedailyfor5daysina9monthspostpartumnursingmother),itwouldnotbeexpectedtocauseanyadverseeffectsinbreastfedinfants,especiallyiftheinfantisolderthan2months.105,106Nodataareavailableregardingtheexcretionofzanamivirinbreastmilk,butduetothepoorinhaledabsorptionandverylowplasmalevels,itwouldnotbeexpectedtocauseanyadverseeffectsinbreastfedinfants.106
Anxiolyticsandsedatives
Lorazepam,oxazepam
Ifusedoccasionallyasasedative,benzodiazepinesarenotcontraindicatedduringbreastfeeding.107Benzodiazepineswithshorterhalflives,lowerlipophilicityandnoactivemetabolitesarepreferredinbreastfeedingmothers(e.g.,oxazepam,lorazepam).Benzodiazepinestakenoveralongerperiodoftimetotreatchronicmaternalconditionsmaybeofconcern.Thebenzodiazepinesandtheirmetabolitesareexcretedinbreastmilk,arepoorlymetabolizedbytheneonate,andhavebeenassociatedwithdrowsinessinnursinginfants.Consequently,discouragethechronicuseofabenzodiazepineinbreastfeedingmothersunlesstheinfant'sconditioniscloselymonitored.
Asthmatherapy Inhaledbronchodilators,inhaledcorticosteroids
Inhaledbronchodilatorsandinhaledcorticosteroidsareacceptableduringbreastfeedingasbioavailabilityandmaternalserumlevelsarelow.108Theaverageamountofterbutalineanexclusivelybreastfedinfantwouldreceiverangesfrom0.20.7%oftheweightadjustedmaternaldose.bSerumlevelswereundetectableintheinfantinonecase.109,110Theamountofinhaledbudesonideinbreastmilkislow(0.3%oftheweightadjustedmaternaldoseb).111Nodataareavailableregardingtheexcretionofomalizumabintobreastmilk.Dataonexcretionoftheleukotrienereceptorinhibitormontelukastintomilkarelacking.However,itdoesnotpenetratetheCNSormanyothertissuesandishighlyproteinbound,makingtheprobabilityofthebabybeingexposedviabreastmilklikelyverylow.7Themanufacturerofzafirlukastindicatesthatitisexcretedintomilkinlowconcentrations(0.5%oftheweightadjustedmaternaldoseb).112Ithasbeenusedinchildrenas
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 10/19
youngas12months.113
Contraceptives Progestinonlyformulations
Progestinonlycontraceptivesshouldbeconsideredforpostpartumwomenandmaybeintroducedimmediatelyafterdelivery(or46weekspostpartuminthecaseoflevonorgestrelintrauterinedevicetoallowtimeforuterineinvolution).Estrogencontainingcontraceptives(includingpills,patch,vaginalring)shouldnotbestarteduntilbreastfeedingisfullyestablished(approximately6weeks)asevenlowdoseformulationscandecreasemilkyield.114
Corticosteroids Prednisolone,prednisone
Prednisoneandprednisoloneareexcretedinbreastmilkinlowamountsandarenotexpectedtocauseadverseeffectsinthebaby.Dependingonmaternaldoseadministered,babywillbeexposedto110%ofaneonataldose.11,115Theoretically,highdosemethylprednisoloneintravenouspulsetherapymayresultinbreastmilklevelsthatcouldapproachtherapeuticdosesforthenursinginfant.Recommendationsforthetimeperiodduringwhichtoavoidbreastfeedingaftertheinfusionrangefrom448hours.14
Decongestants,oral
Pseudoephedrine 5.5%oftheweightadjustedmaternaldosagebisexcretedinbreastmilkafterasingleoraldoseof60mgofpseudoephedrine.Decreasedmilkproductionwasreportedatthesamedosage.Irritabilitywasreportedininfantsexposedtopseudoephedrineinonestudyofbreastfeedingmothers.79,116Useshouldbelimitedtoafewdaysanddiscontinuedifadecreaseinmilkproductionisobserved.Nodataareavailableontheuseofphenylephrineduringbreastfeeding,thereforeanalternatedrugmaybepreferred,especiallywhilenursinganewbornorpreterminfant.Intranasalisotonicsalinesolutionsortopicaldecongestants(oxymetazoline,xylometazoline)arepreferredoveroraldecongestants.
Diabetestherapy Insulin,metformin Humaninsulinisnormallyfoundinbreastmilk.Amountofsyntheticinsulinsecretedintobreastmilkisunknownbut,ifsecreted,thispeptidewouldbedestroyedintheinfant'sGItractwithnosignificantabsorption.7Metforminlevelsinmilkarelowandinfantswouldreceivelessthan0.5%oftheirmother'sweightadjusteddosage.Itissometimesdetectableinlowlevelsintheserumofbreastfedinfantsbutnoadverseeffectsinbreastfedinfantswerereportedinonestudy.Metforminshouldbeusedwithcautionwhilenursingnewbornandprematureinfantsandthosewithrenalimpairment.14Theamountofglyburideexcretedinbreastmilkseemstobelow(lessthan1%oftheweightadjustedmaternaldoseb):noadverseeffectsonbreastfedinfant'sbloodglucosehavebeenreportedbutdataarelimited.117Nodataareavailableregardingtheexcretionofacarboseintobreastmilk.However,lessthan2%ofadoseofacarboseisabsorbedfromthemother'sGItractmakingitunlikelythatanydrugreachestheinfantthroughbreastmilk.118Nodataareavailableregardingtheexcretionofgliclazide,glimepiride,nateglinide,pioglitazone,repaglinideandrosiglitazoneinbreastmilk.Analternatedrugmaybepreferred,especiallywhilenursinganewbornorpreterminfant.Some
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 11/19
expertsrecommendmonitoringthebreastfedinfant'sbloodglucoseduringmaternaltherapywithhypoglycemicagents.118
Gastrointestinaldrugs
Antacids,sucralfate Aluminum,calciumandmagnesiumantacidsandsucralfatearepartiallyorpoorlyabsorbedorallyandareconsideredsafetouse.7
Antidiarrheals Useofloperamideduringbreastfeedingisunlikelytoaffecttheinfantasitisminimallyabsorbedorally.Basedonitschemicalandpharmacologicalsimilaritytonarcotics,occasionalsmalldosesofdiphenoxylatemaybeacceptablewhilebreastfeedinganolderinfant,butalternativesarepreferred,especiallywhilenursinganewborn.7,14
GImotilityagents Theexcretionintomilkofdomperidoneandmetoclopramidearelessthan0.05%and6%respectivelyofadailypediatricdose.Noadverseeventsarereportedfordomperidonebutintestinaldiscomfortwasreportedin2breastfedinfantsofmotherstakingmetoclopramide.119,120,121Domperidoneisusedtoincreasemilkproductioninsomewomenwhodonotrespondtoanonpharmacologicapproach.
H2antagonists Thoughconsideredsafeforusebybreastfeedingmothers,cimetidineandranitidinemayconcentrateinmilkwhereasfamotidineandnizatidinehavethelowestconcentrations,makingthempreferablechoices.7,23Ranitidinehasbeenwidelyusedinpediatricsprimarilyforgastroesophagealreflux.Adverseeffectshavenotbeenreportedinnursinginfants.
Laxatives PsylliumisacceptabletouseduringbreastfeedingbecauseitisnotabsorbedfromtheGItract.Therehavebeennocasesofloosestoolsreportedinbreastfedinfants.14Docusate,bisacodylandmagnesiumhydroxidearenotappreciablyabsorbedfromtheGItractandthereforethesedrugsareunlikelytobefoundinthematernalserumorbreastmilk.7,14Onepostpartumpatientreceivingalaxativecontainingdocusateinadoseof120mgdailyinadditiontodanthron100mgdailystatedthatdiarrheaoccurredinherbreastfedinfant.14Usualdosesofsennaareacceptabletouseduringbreastfeeding.However,alaxativeeffectwasobservedinafewcasereports.Cascaraisnotafirstlinechoiceduetocasereportsofalaxativeeffectinbreastfedinfantsandunknownoralabsorption.7,14Nodataareavailableregardingtheexcretionoflactuloseintobreastmilkhoweverlessthan3%ofadoseoflactuloseisabsorbedfromthemother'sGItract,makingitunlikelythatanydrugreachestheinfantthroughbreastmilk.11Oralpolyethyleneglycol(e.g.,PEG3350)andrectalglycerinarenegligiblyabsorbedfromtheGItractandunlikelytohavesignificantlevelsinbreastmilk.11
Misoprostol Misoprostollevelsinbreastmilkarelowamountingestedbythe
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 12/19
nursinginfantwouldnotbeexpectedtocauseadverseeffects.14
Protonpumpinhibitors
Protonpumpinhibitorsareunstableinanacidmilieuand,wheningestedviamilk,wouldprobablybedestroyedintheinfant'sstomachpriortoabsorption.7Pantoprazoleandomeprazoleareexcretedinmilkinsmallquantities.122,123Lansoprazoleandomeprazoleareusedforthetreatmentofgastroesophagealrefluxinneonatesandpediatrics.Esomeprazoleisthesenantiomerofomeprazoleandthereforewouldalsonotbeexpectedtocauseanyadverseeffectsinbreastfedinfants.123
Migrainetherapy Eletriptan,sumatriptan
Occasionaluseofsumatriptanandeletriptanseemstobeacceptablebecausetheamountofthesedrugsexcretedintomilkislow(3.5%and0.02%oftheweightadjustedmaternaldosage,brespectively).Dataonalmotriptan,frovatriptan,naratriptan,rizatriptanandzolmitriptanarelacking.7Becausethereislimitedpublishedexperiencewithergotamine,dihydroergotamineandmethysergideduringbreastfeeding,andadverseeffectsintheinfantcannotberuledout,mostauthoritiesconsiderthesedrugstobeundesirabletousewhilenursing.7,14
Musclerelaxants Cyclobenzaprine,methocarbamol
Theexcretionofcyclobenzaprine,methocarbamolandorphenadrineintomilkhasnotbeenreported.However,occasionalcyclobenzaprineandmethocarbamolexposuresareacceptablebecauseofcyclobenzaprine'sstructuralsimilaritiestoamitriptyline(seeAntidepressants)andtheveryshorthalflifeofmethocarbamol.Noadverseeventshavebeenpublished,butinfants(especiallythosethatarenewbornorpremature)shouldbemonitoredforsedationwhilenursing.7
NSAIDs Diclofenac,flurbiprofen,ibuprofen,indomethacin,naproxen
MostNSAIDshavebeenshowntobepresentinbreastmilkinsmallamountsandareconsideredsafetouse.Theuseofshortactingdrugs,suchasibuprofenandflurbiprofen,maybepreferredoverthosewithalongerhalflifesuchasnaproxen.7Lessthan1%ofthepediatricdoseofdiclofenacisexcretedintobreastmilk.Diclofenacalsohasashorthalflife.14,126Theamountofindomethacinexcretedinbreastmilkislessthan4%ofatypicalneonataldoseanditisconsideredsafetousewhilebreastfeeding.However,otheragentswithmorepublishedinformationonuseduringbreastfeedingmaybepreferableespeciallywhilenursinganewbornorpreterminfant.11Dataoncelecoxibarelimitedtoafewinfantsbutmilklevelswerelowandadverseeffectswerenotnotedwhentakenshortterm.7Moredataareneededtodeterminerisksincethedrughasalonghalflifeandhighoralabsorption.
Scabicides,pediculicides
Permethrin Permethrin5%creamisthetreatmentofchoiceforscabies.Permethrin1%orpyrethrins/piperonylbutoxidemaybeusedforthetreatmentofheadlicewhilebreastfeeding.124Topicalabsorptionofpermethrinandpyrethrinsislow.Permethrinisrapidlymetabolizedtoinactivemetabolitesandexcretedinurine.Overttoxicityisunlikely.Avoidapplicationonnipples.Percutaneousabsorptionofpiperonylbutoxideisunknown.7,125
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 13/19
Lindaneisnotrecommendedbecauseitisabsorbedthroughthemother'sskinandexcretedintomilkfat.Directcontactoflindanewithneonatalskinresultsinsignificantabsorption.Directexposureispotentiallytoxicininfantswithreportsofelevatedliverenzymes,seizuredisordersandhypersensitivity.Itmayalsohaveestrogeniceffectsthatcouldinhibitlactation.14,125LindaneisnotcurrentlyavailableinCanada.
Smokingcessation
Nicotinereplacementtherapy
Dataonnicotinepatchesarelimitedbuttheamountofnicotineandcotinineexcretedinbreastmilkseemtobelessthan8%oftheweightadjustedmaternaldoseb.Witha21mgtransdermalpatch,nicotinepassesintobreastmilkinamountsequivalenttosmoking17cigarettesdaily.Lowerpatchstrengthsof7and14mgprovideproportionatelyloweramountsofnicotinetothebreastfedinfant.Nostudiesonnicotinesprayornicotinegumuseinnursingmothershavebeenreported.Nicotinegummayproducelargevariationsinpeaklevelswhengumischewedrapidly:fluctuationssimilartosmokingitself.Somecliniciansrecommendtowait23hafterusingthegumbeforebreastfeeding.127DataonvareniclinearelackingbuttransferispossibleandeffectonCNSisaconcern.7Forinformationontheuseofbupropionduringbreastfeeding,seeAntidepressants.
Thyroidagents Antithyroidagents Theestimatedlevelofexposuretopropylthiouracilinbreastfeedinginfantsislessthan1%ofthetherapeuticdosestandardizedbyweight,andthethyroidfunctionoftheinfantisnotaffected.128Methimazoleindosesupto20mg/dayhasbeendocumentednottoaffecttheinfant'sthyroidfunction.129,130,131Foreitherdrug,noadverseeffectsinbreastfedinfantshavebeenreportedsofarandmonitoringofinfants'thyroidfunctionisnotnecessaryifdevelopmentisprogressingnormally.131
Thyroidhormones Levothyroxineiscompatiblewithbreastfeeding.Thyroidhormonescrossintobreastmilkinlowamounts.Theirpresenceisnotlikelytoaffecttheinfant'sthyroid.23
Vaccines WomenwhoarebreastfeedingcanbevaccinatedwithTd,Tdap,pneumococcal,meningococcal,hepatitisA,hepatitisB,HPV,rabies,typhoid,MMR,varicella,HPVandcholeravaccinesifindicated.SafetyoftheJapaneseencephalitisvaccineinbreastfeedingisunknownanditshouldbeadministeredonlyiftheriskofdiseaseoutweighstheunknownriskofvaccination.YellowfevervaccineisnotrecommendedforbreastfeedingwomenandBCGvaccineshouldbeusedwithcaution.Womenwhoreceivesmallpoxvaccineaspostexposureprophylaxisshouldavoidbreastfeedingandotherclosecontactwiththeirbabyuntilthescabhasseparatedfromthevaccinationsite.132
a.Thislistisnotexhaustiveordefinitive.Drugsnotlistedinthetablearenotnecessarilycontraindicated.Individualizedriskassessmentisrequiredwhenprescribinganymedicationtoabreastfeedingwoman.b.Weightadjustedmaternaldoseisamother'sdosebasedonbodyweight(e.g.,mg/kg).Expertsrecommendthatanamountof
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 14/19
drugreceivedbytheinfantviabreastmilkwhichis>10%oftheweightadjustedmaternaldoseshouldbeatheoreticallevelofconcernwhenconsideringtheacceptabilityofdrugexposure.Theestimatedamountofdrugreceivedbytheinfantviabreastmilkiscalculatedbymultiplyingthestandardmilkintake(150mL/kg/day)bythedrugconcentrationinbreastmilk.
Abbreviations:G6PD=glucose6phosphatedehydrogenaseGFR=glomerularfiltrationrate
DrugsforNonmedicalUse
TobaccosmokingandalcoholingestionarethemostcommonsourcesofnonmedicinaldrugexposureinbreastfedinfantsinCanada.Becausetheysooftenoccurinthesameindividual,itisdifficulttostudytheirindependenteffects.Increasingly,thesedrugsareusedtogetherwithillicitdrugssuchasmarijuanaandcocaine.
Table2:BreastfeedingandNonmedicalUseofDrugs
Drug Comments
Alcohol Notcompatiblewithbreastfeeding.Thealcoholmetabolizingcapacity(alcoholandaldehydedehydrogenase)isprematurethroughouttheneonatalandinfantileperiod.Overall,motordevelopmentisslightlyslowerininfantsbreastfedbymotherswhoregularlydrinkalcohol.Chronicorheavyconsumersofalcoholshouldnotbreastfeed.7Shorttermalcoholconsumptionbynursingmothersreportedlyhasanimmediateeffectontheodourcharacteristicsofthemilkandthefeedingbehaviouroftheirinfants,resultinginlessconsumptionofmilk.133Toavoidexposureoftheinfanttoalcohol,breastfeedingmothersshouldnotconsumealcoholorshouldconsumenomorethanonedrink23hbeforebreastfeeding.7
Caffeine Hypothetically,anursinginfantingests0.11%ofthematernaldoseafterthemotherdrinks12cupsofcoffee.Thisisaninsignificantamountofthedrug,butitmustberememberedthatthehalflifeofcaffeineis80hinthetermnewbornand97.5hinaprematureinfant(2030timesthatofanadult).Therefore,repeatedingestionmightleadtoaccumulationofcaffeineintheinfantduringthefirst2weeksofpostnatallife.Thishasyettobestudied.
Recreationalorstreetdrugs
Nosystematicstudiesofrecreationalorstreetdrug(ordrugmetabolite)excretionexist.
Tobacco Discourageduringbreastfeedingbecausetherearewelldocumentedhealthriskstothemotherandinfantfromsecondhandsmoke.Infantexposuretonicotineislargelythroughinhalationofsecondhandsmoke.Inmothersunwillingtostopsmokingduringbreastfeeding,itshouldbenotedthatbreastfedbabiesofmotherswhocontinuetosmokehavebetterimmunityandlessrespiratoryinfectionsthanbottlefedbabiesofmotherswhocontinuetosmoke.134
Nicotineisconcentratedinhumanbreastmilk.135,136Onestudysuggeststhatcigarettesmokingsignificantlyreducesbreastmilkproduction.137Encouragenursingmotherstospeaktotheirhealthcareprovidersregardingoptionsforsmokingcessation.
References
1. KramerMS,AboudF,MironovaEetal.Breastfeedingandchildcognitivedevelopment:newevidencefromalargerandomizedtrial.ArchGenPsychiatry200865(5):57884.
2. VerhasseltV,MilcentV,CazarethJetal.Breastmilkmediatedtransferofanantigeninducestoleranceand
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 15/19
protectionfromallergicasthma.NatMed200814(2):1705.3. SectiononBreastfeeding.Breastfeedingandtheuseofhumanmilk.Pediatrics2012129(3):e82741.4. SachsHCCommitteeonDrugs.Thetransferofdrugsandtherapeuticsintohumanbreastmilk:anupdate
onselectedtopics.Pediatrics2013132(3):e796809.5. AkusM,BartickM.Lactationsafetyrecommendationsandreliabilitycomparedin10medicationresources.
AnnPharmacother200741(9):135260.6. HealthCanadaJanssenOrtho.ImportantsafetyinformationaboutuseofTylenolwithCodeineNo.2,3,4
andelixirinnursingmothersandultrarapidmetabolizersofcodeineOctober6,2008.Availablefrom:healthycanadians.gc.ca/recallalertrappelavis/hcsc/2008/14526aeng.php.AccessedOctober1,2013.
7. HaleTW.Medicationsandmothers'milk:amanualoflactationalpharmacology.15thed.Amarillo(TX):HalePublishing2012.
8. WittelsB,ScottDT,SinatraRS.Exogenousopioidsinhumanbreastmilkandacuteneonatalneurobehavior:apreliminarystudy.Anesthesiology199073(5):8649.
9. LamJ,KellyL.CiszkowskiCetal.Centralnervoussystemdepressionofneonatesbreastfedbymothersreceivingoxycodoneforpostpartumanalgesia.JPediatr2012160(1):337.
10. SeatonS,ReevesM,McLeanS.OxycodoneasacomponentofmultimodalanalgesiaforlactatingmothersafterCaesareansection:relationshipsbetweenmaternalplasmabreastmilkandneonatalplasmalevels.AustNZJObstetGynaecol200747(3):1815.
11. FerreiraE,MartinB,MorinC.Grossesseetallaitement:guidethrapeutique.2nded.Montral(QC):CHUSainteJustine2013.
12. RobieuxI,KorenG,VandenberghHetal.Morphineexcretioninbreastmilkandresultantexposureofanursinginfant.ClinToxicol199028(3):36570.
13. IlettKF,PaechMJ,PageSharpMetal.UseofasparsesamplingstudydesigntoassesstransferoftramadolanditsOdesmethylmetaboliteintotransitionalbreastmilk.BrJClinPharmacol200865(5):6616.
14. DrugsandLactationDatabase(LactMed).Bethesda(MD):U.S.NationalLibraryofMedicine.Availablefrom:toxnet.nlm.nih.gov/cgibin/sis/htmlgen?LACT.AccessedOctober2,2013.
15. ChanCF,PageSharpM,KristensenJHetal.Transferofnaltrexoneanditsmetabolite6,betanaltrexolintohumanmilk.JHumLact200420(3):3226.
16. SedlmayrT,PetersF,RaaschWetal.[Clarithromycin,anewmacrolideantibiotic.Effectivenessinpuerperalinfectionsandpharmacokineticsinbreastmilk].GeburtshilfeFrauenheilkd199353(7):48891.[German].
17. KelseyJJ,MoserLR,JenningsJCetal.Presenceofazithromycinbreastmilkconcentrations:acasereport.AmJObstetGynecol1994170(5Pt1):13756.
18. ZaoJ,KorenG,BozzoP.Usingnitrofurantionwhilebreastfeedinganewborn.CanFamPhys201460(6):53940.
19. GuillonneauM,deCrepyA,AufrantCetal.[Breastfeedingispossibleincaseofmaternaltreatmentwithenoxaparin].ArchPediatr19963(5):5134.[French].
20. HarenbergJ,LeberG,ZimmermannRetal.[Preventionofthromboembolismwithlowmolecularweightheparininpregnancy].GeburtshilfeFrauenheilkd198747(1):158.[German].
21. RichterC,SitzmannJ,LangPetal.Excretionoflowmolecularweightheparininhumanmilk.BrJClinPharmacol200152(6):70810.
22. LindhoffLastE,BauersachsR.Heparininducedthrombocytopeniaalternativeanticoagulationinpregnancyandlactation.SeminThrombHemost200228(5):43946.
23. BriggsGG,FreemanRK,YaffeSJ.Drugsinpregnancyandlactation:areferenceguidetofetalandneonatal
risk.9thed.Philadelphia(PA):LippincottWilliams&Wilkins2011.24. FreyOR,ScheidtP,vonBrenndorffAI.Adverseeffectsinanewborninfantbreastfedbyamothertreated
withdoxepin.AnnPharmacother199933(6):6903.25. BirnbaumCS,CohenLS,BaileyJWetal.Serumconcentrationsofantidepressantsandbenzodiazepinesin
nursinginfants:acaseseries.Pediatrics1999104(1):e11.26. StoweZN,HostetterAL,OwensMJetal.Thepharmacokineticsofsertralineexcretionintohumanbreast
milk:determinantsofinfantserumconcentrations.JClinPsychiatry200364(1):7380.27. DoddS,StockyA,BuistAetal.Sertralineinpairedbloodplasmaandbreastmilksamplesfromnursing
mothers.HumPsychopharmacol200015(4):161264.28. EppersonN,CzarkowskiKA,WardO'BrienDetal.Maternalsertralinetreatmentandserotonintransportin
breastfeedingmotherinfantpairs.AmJPsychiatry2001158(10):16317.29. MllerMJ,PreuC,PaulTetal.Serotonergicoverstimulationinapreterminfantaftersertralineintakevia
breastmilk.BreastfeedMed20138(3):3279.
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 16/19
30. HendrickV,FukuchiA,AltshulerLetal.Useofsertraline,paroxetineandfluvoxaminebynursingwomen.BrJPsychiatry2001179:1636.
31. BeggEJ,DuffullSB,SaundersDAetal.Paroxetineinhumanmilk.BrJClinPharmacol199948(2):1427.32. OhmanR,HaggS,CarleborgLetal.Excretionofparoxetineintobreastmilk.JClinPsychiatry
199960(8):51923.33. StoweZN,CohenLS,HostetterAetal.Paroxetineinhumanbreastmilkandnursinginfants.AmJPsychiatry
2000157(2):1859.34. MisriS,KimJ,RiggsKWetal.Paroxetinelevelsinpostpartumdepressedwomen,breastmilk,andinfant
serum.JClinPsychiatry200061(11):82832.35. EppersonCN,JatlowP,CzarkowskiKetal.Maternalfluoxetinetreatmentinthepostpartumperiod:effects
onplateletserotoninandplasmadruglevelsinbreastfeedingmotherinfantpairs.Pediatrics2003112(5):e4259.
36. MorettiME,SharmaA,BarOzBetal.Fluoxetineanditseffectsonthenursinginfant:aprospectivecohortstudy.ClinPharmacolTher199965(2):141.
37. KristensenJH,IlettKF,HackettLPetal.Distributionandexcretionoffluoxetineandnorfluoxetineinhumanmilk.BrJClinPharmacol199948(4):5217.
38. TaddioA,ItoS,KorenG.Excretionoffluoxetineanditsmetabolite,norfluoxetine,inhumanbreastmilk.JClinPharmacol199636(1):427.
39. YoshidaK,SmithB,CraggsMetal.Fluoxetineinbreastmilkanddevelopmentaloutcomeofbreastfedinfants.BrJPsychiatry1998172:1758.
40. ChambersCD,AndersonPO,ThomasRGetal.Weightgainininfantsbreastfedbymotherswhotakefluoxetine.Pediatrics1999104(5):e61.
41. LesterBM,CuccaJ,AndreozziLetal.Possibleassociationbetweenfluoxetinehydrochlorideandcolicinaninfant.JAmAcadChildAdolescPsychiatry199332(6):12535.
42. HaleTW,ShumS,GrossbergM.Fluoxetinetoxicityinabreastfedinfant.ClinPediatr(Phila)200140(12):6814.
43. SuriR,StoweZN,HendrickVetal.Estimatesofnursinginfantdailydoseoffluoxetinethroughbreastmilk.BiolPsychiatry200252(5):44651.
44. PiontekCM,WisnerKL,PerelJM.Serumfluvoxaminelevelsinbreastfedinfants.JClinPsychiatry200162(2):1113.
45. KristensenJH,HackettLP,KohanRetal.Theamountoffluvoxamineinmilkisunlikelytobeacauseofadverseeffectsinbreastfedinfants.JHumLact200218(2):13943.
46. RamponoJ,KristensenJH,HackettLPetal.Citalopramanddemethylcitalopraminhumanmilkdistribution,excretionandeffectsinbreastfedinfants.BrJClinPharmacol200050(3):2638.
47. SchmidtK,OlesenOV,JensenPN.Citalopramandbreastfeeding:serumconcentrationandsideeffectsintheinfant.BiolPsychiatry200047(2):1645.
48. SpigsetO,CarieborgL,OhmanRetal.Excretionofcitalopraminbreastmilk.BrJClinPharmacol199744(3):2958.
49. HeikkinenT,EkbladU,KeroPetal.Citalopraminpregnancyandlactation.ClinPharmacolTher200272(2):18491.
50. HendrickV,AltshulerL,WertheimerAetal.Venlafaxineandbreastfeeding.AmJPsychiatry2001158(12):208990.
51. IlettKF,HackettLP,DusciLJetal.DistributionandexcretionofvenlafaxineandOdesmethylvenlafaxineinhumanmilk.BrJClinPharmacol199845(5):45962.
52. IlettKF,KristensenJH,HackettLPetal.DistributionofvenlafaxineanditsOdesmethylmetaboliteinhumanmilkandtheireffectsinbreastfedinfants.BrJClinPharmacol200253(1):1722.
53. RamponoJ,TeohS,HackettLPetal.Estimationofdesvenlafaxinetransferintomilkandinfantexposureduringitsuseinlactatingwomenwithpostnataldepression.ArchWomensMentHealth201114(1):4953.
54. BriggsGG,SamsonJH,AmbrosePJetal.Excretionofbupropioninbreastmilk.AnnPharmacother199327(4):4313.
55. BaabSW,PeindlKS,PiontekCMetal.Serumbupropionlevelsin2breastfeedingmotherinfantpairs.JClinPsychiatry200263(10):9101.
56. HaasJS,KaplanCP,BarenboimDetal.Bupropioninbreastmilk:anexposureassessmentforpotentialtreatmenttopreventpostpartumtobaccouse.TobControl200413(1):526.
57. AichhornW,WhitworthAB,WeissUetal.Mirtazapineandbreastfeeding.AmJPsychiatry2004161(12):2325.
58. KristensenJH,IlettKF,RamponoJetal.Transferofantidepressantmirtazapineintobreastmilk.BrJClin
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 17/19
Pharmacol200763(3):3227.59. BuistA,DennersteinL,MaguireKPetal.Plasmaandhumanmilkconcentrationsofmoclobemideinnursing
mothers.HumanPsychopharmacolClinExp199813(8):57982.60. ChaudronLH,SchoeneckerCJ.Bupropionandbreastfeeding:acaseofapossibleinfantseizure.JClin
Psychiatry200465(6):8812.61. CorriveauD.UtilisationdeWellbutrinSRchezlafemmeenceinteetchezlafemmeallaitant.In:
GlaxoSmithKline,PersonalCommunication2001.62. NeumanG,ColantonioD,DelaneySetal.Bupropionandescitalopramduringlactation.AnnPharmacother
201448(7):92831.63. VerbeekRK,RossSG,McKennaEA.Excretionoftrazodoneinbreastmilk.BrJClinPharmacol
198622(3)36770.64. MisriS,CorralM,WardropAAetal.Quetiapineaugmentationinlactation:aseriesofcasereports.JClin
Psychopharmacol200626(5):50811.65. MisriS,SivertzK.Tricyclicdrugsinpregnancyandlactation:apreliminaryreport.IntJPsychiatryMed
199121(2):15771.66. NewportDJ,RitchieJC,KnightBTetal.Venlafaxineinhumanbreastmilkandnursinginfantplasma:
determinationofexposure.JClinPsychiatry200970(9):130410.67. LoboED,LoghinC,KnadlerMPetal.Pharmacokineticsofduloxetineinbreastmilkandplasmaofhealthy
postpartumwomen.ClinPharmacokinet200847(2):1039.68. BoycePM,HackettLP,IlettKF.Duloxetinetransferacrosstheplacentaduringpregnancyandintomilkduring
lactation.ArchWomensMentHealth201114(2):16972.69. MeadorKJ.Breastfeedingandantiepilepticdrugs.JAMA2014311(17):17978.70. ItoS.Drugtherapyforbreastfeedingwomen.NEnglJMed2000343(2):11826.71. OhmanI,VitolsS,TomsonT.Pharmacokineticsofgabapentinduringdelivery,intheneonatalperiod,and
lactation:doesafetalaccumulationoccurduringpregnancy?Epilepsia200546(10):16214.72. OhmanI,TomsonT.Gabapentinkineticsduringdelivery,intheneonatalperiod,andduringlactation.
Epilepsia200950(Suppl10):108.73. KristensenJH,IlettKF,HackettLPetal.Gabapentinandbreastfeeding:acasereport.JHumLact
200622(4):4268.74. MactalHaafC,HoffmanM,KuchtaA.Useofantiinfectiveagentsduringlactation,Part3:Antivirals,
antifungals,andurinaryantiseptics.JHumLact200117(2):1606.75. IlettKF,KristensenJH.Druguseandbreastfeeding.ExpertOpinDrugSaf20054(4):74568.76. ReedBR.Dermatologicdruguseduringpregnancyandlactation.DermatolClin199715(1):197206.77. HilbertJ,RadwanskiE,AffrimeMBetal.Excretionofloratadineinhumanbreastmilk.JClinPharmacol
198828(3):2349.78. LucasBD,PurdyCY,ScarimSKetal.Terfenadinepharmacokineticsinbreastmilkinlactatingwomen.Clin
PharmacolTher199557(4):398402.79. ItoS,BlajchmanA,StephensonMetal.Prospectivefollowupofadversereactionsinbreastfedinfants
exposedtomaternalmedication.AmJObstetGynecol1993168(5):13939.80. SandstromB,RegardhCG.Metoprololexcretionintobreastmilk.BrJClinPharmacol19809(5):5189.81. HoTK,MorettiME,SchaefferIJetal.Maternalbetablockerusageandbreastfeedingintheneonate.Pediatr
Res199945(4):67A.82. SchimmelMS,EidelmanAI,WilschanskiMAetal.Toxiceffectsofatenololconsumedduringbreastfeeding.J
Pediatr1989114(3):4768.83. DumezY,TchobroutskyC,HornychHetal.Neonataleffectsofmaternaladministrationofacebutolol.BrMed
J(ClinResEd)1981283(6299):10779.84. BoutroyMJ,BianchettiG,DubrucCetal.Tonursewhenreceivingacebutolol:isitdangerousforthe
neonate?EurJClinPharmacol198630(6):7379.85. JonesHM,CummingsAJ.Astudyofthetransferofalphamethyldopatothehumanfoetusandnewborn
infant.BrJClinPharmacol19786(5):4324.86. WhiteWB,AndreoliJW,CohnRD.Alphamethyldopadispositioninmotherswithhypertensionandintheir
breastfedinfants.ClinPharmacolTher198537(4):38790.87. CommitteetoAdviseonTropicalMedicineandTravel(CATMAT).Canadianrecommendationsforthe
preventionandtreatmentofmalariaamonginternationaltravellers.CanCommunDisRep200430(Suppl1):162.Availablefrom:www.phacaspc.gc.ca/publicat/ccdrrmtc/09vol35/35s1/page5eng.php.AccessedOctober2,2013.
88. Recommendationsforthepreventionofmalariaamongtravelers.MMWRRecommRep199039(RR3):110.
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 18/19
Availablefrom:www.cdc.gov/mmwr/preview/mmwrhtml/00001584.htm.AccessedOctober2,2013.89. VigueraAC,NewportDJ,RitchieJetal.Lithiuminbreastmilkandnursinginfants:clinicalimplications.AmJ
Psychiatry2007164(2):3425.90. TunnessenWW,HertzCG.Toxiceffectsoflithiuminnewborninfants:acommentary.JPediatr
197281(4):8047.91. MorettiM,KorenG,VerjeeZetal.Monitoringlithiuminbreastmilk:anindividualizedapproachforbreast
feedingmothers.TherDrugMonit200325(3):3646.92. KirkM.ZyprexaEmploichezlesfemmesenceintesouallaitantes.In:TouzinJ,ed.Toronto(ON):EliLilly
Canada,Inc.2008:15.93. GiladO,MerlobP,StahlBetal.Outcomeofinfantsexposedtoolanzapineduringbreastfeeding.Breastfeed
Med20116(2):558.94. GardinerSJ,KristensenJH,BeggEJetal.Transferofolanzapineintobreastmilk,calculationofinfantdrug
dose,andeffectonbreastfedinfants.AmJPsychiatry2003160(8):142831.95. BrunnerE,FalkDM,JonesMetal.Olanzapineinpregnancyandbreastfeeding:areviewofdatafromglobal
safetysurveillance.BMCPharmacolToxicol201314:38.96. LeeA,GiesbrechtE,DunnEetal.Excretionofquetiapineinbreastmilk.AmJPsychiatry2004161(9):1715
6.97. RamponoJ,KristensenJH,IlettKFetal.Quetiapineandbreastfeeding.AnnPharmacother200741(4):711
4.98. YazdaniBrojeniP,TaguchiN,GarciaBournissenFetal.Quetiapineinhumanmilkandsimulationbased
assessmentofinfantexposure.ClinPharmacolTher201087(Suppl1):S34.99. WeggelaarNM,KeijerWJ,JanssenPK.Acasereportofrisperidonedistributionandexcretionintohuman
milk:howtogivegoodadviceifyouhavenotenoughdataavailable.JClinPsychopharmacol201131(1):12931.
100. YoshidaK,SmithB,CraggsMetal.Neurolepticdrugsinbreastmilk:astudyofpharmacokineticsandofpossibleadverseeffectsinbreastfedinfants.PsycholMed199828(1):8191.
101. DevVJ,KruppP.Adverseeventprofileandsafetyofclozapine.RevContempPharmacother19956:197208.
102. SheffieldJS,FishDN,HollierLMetal.Acyclovirconcentrationsinhumanbreastmilkaftervalacicloviradministration.AmJObstetGynecol2002186(1):1002.
103. SieverLJ.Theeffectofamantadineonprolactinlevelsandgalactorrheaonneuroleptictreatedpatients.JClinPsychopharmacol19811(1):27.
104. CorreaN,OplerLA,KaySRetal.Amantadineinthetreatmentofneuroendocrinesideeffectsofneuroleptics.JClinPsychoharmacol19877(2):915.
105. WentgesvanHoltheN,vanEijkerenM,vanderLaanJW.Oseltamivirandbreastfeeding.IntJInfectDis200812(4):451.
106. TanakaT,NakajimaK,MurashimaAetal.SafetyofneuraminidaseinhibitorsagainstnovelinfluenzaA(H1N1)inpregnantandbreastfeedingwomen.CMAJ2009181(12):558.
107. KellyLE,PoonS,MadadiPetal.Neonatalbenzodiazepinesexposureduringbreastfeeding.JPediatr2012161(3):44851.
108. NAEPPexpertpanelreport.Managingasthmaduringpregnancy:recommendationsforpharmacologictreatment2004update.JAllergyClinImmunol2005115(1):3446.
109. LindbergC,BoreusLO,deChateauPetal.Transferofterbutalineintobreastmilk.EurJRespDis1984134:8791.
110. LonnerholmG,LindstromB.Terbutalineexcretionintobreastmilk.BrJClinPharmacol198213(5):72930.111. FaltA,BengtssonT,KennedyBMetal.Exposureofinfantstobudesonidethroughbreastmilkofasthmatic
mothers.JAllergyClinImmunol2007120(4):798802.112. eCPS.Ottawa(ON):CanadianPharmacistsAssociation2013.Accolate[productmonograph].Available
from:www.etherapeutics.ca.Subscriptionrequired.113. BerlinCM,BriggsGG.Drugsandchemicalsinhumanmilk.SeminFetalNeonatalMed200510(2):14959.114. BlackA,FrancoeurD,RoweTetal.Canadiancontraceptionconsensus.JObstetGynaecolCan
200426(4):34787,389436.115. OstL,WettrellG,BjorkhemIetal.Prednisoloneexcretioninhumanmilk.JPediatr1985106(6):100811.116. AljazafK,HaleTW,IlettKFetal.Pseudoephedrine:effectsonmilkproductioninwomenandestimationof
infantexposureviabreastmilk.BrJClinPharmacol200356(1):1824.117. FeigDS,BriggsGG,KraemerJMetal.Transferofglyburideandglipizideintobreastmilk.DiabetesCare
200528(8):18515.
8/4/2015 eTherapeutics+Complete:TherapeuticChoices:DrugUseduringBreastfeeding
https://www.etherapeutics.ca/tc.showPrintableChapter.action?chapterId=ci709 19/19
118. EverettJA.Useoforalantidiabeticagentsduringbreastfeeding.JHumLact199713(4):31921.119. KauppilaA,ArvelaP,KoivistoMetal.Metoclopramideandbreastfeeding:transferintomilkandthe
newborn.EurJClinPharmacol198325(6):81923.120. KauppilaA,AnuntiP,KivinenSetal.Metoclopramideandbreastfeeding:efficacyandanteriorpituitary
responsesofthemotherandthechild.EurJObstetGynecolReprodBiol198519(1):1922.121. LewisPJ,DevenishC,KahnC.Controlledtrialofmetoclopramideintheinitiationofbreastfeeding.BrJClin
Pharmacol19809(2):2179.122. PlanteL,FerronGM,UnruhMetal.Excretionofpantoprazoleinhumanbreast.JReprodMed
200449(10):8257.123. MarshallJK,ThompsonAB,ArmstrongD.Omeprazoleforrefractorygastroesophagealrefluxdiseaseduring
pregnancyandlactation.CanJGastroenterol199812(3):2257.124. CentersforDiseaseControlandPrevention,WorkowskiKA,BermanSM.Sexuallytransmitteddiseases
treatmentguidelines,2006.MMWRRecommRep200655(RR11):194.125. PortoI.Antiparasiticdrugsandlactation:focusonanthelmintics,scabicides,andpediculicides.JHumLact
200319(4):4215.126. TaketomoCK,HoddingJH,KrausDM.Pediatric&neonataldosagehandbook:acomprehensiveresourcefor
allclinicianstreatingpediatricandneonatalpatients.18thed.Hudson(OH):Lexicomp2011.127. IlettKF,HaleTW,PageSharpMetal.Useofnicotinepatchesinbreastfeedingmothers:transferofnicotine
andcotinineintohumanmilk.ClinPharmacolTher200374(6):51624.128. KampmannJP,JohansenK,HansenJMetal.Propylthiouracilinhumanmilk.Revisionofadogma.Lancet
19801(8171):7367.129. AziziF.Effectofmethimazoletreatmentofmaternalthyrotoxicosisonthyroidfunctioninbreastfeeding
infants.JPediatr1996128(6):8558.130. AziziF,KhoshniatM,BahrainianMetal.Thyroidfunctionandintellectualdevelopmentofinfantsnursedby
motherstakingmethimazole.JClinEndocrinolMetab200085(9):32338.131. MandelSJ,CooperDS.Theuseofantithyroiddrugsinpregnancyandlactation.JClinEndocrinolMetab
200186(6):23549.132. Part3:Vaccinationofspecificpopulations.Immunizationinpregnancyandbreastfeeding.In:PublicHealth
AgencyofCanada.Canadianimmunizationguide.Availablefrom:www.phacaspc.gc.ca/publicat/ciggci/p0304eng.php#a8.AccessedNovember19,2013.
133. MennellaJA,BeauchampGK.Thetransferofalcoholtohumanmilk.Effectsonflavorandtheinfant'sbehavior.NEnglJMed1991325(14):9815.
134. DoreaJG.Maternalsmokingandinfantfeeding:breastfeedingisbetterandsafer.MaternChildHealthJ200711(3):28791.
135. LuckW,NauH.Nicotineandcotinineconcentrationsinserumandmilkofnursingsmokers.BrJClinPharmacol198418(1):915.
136. HardeeGE,StewartT,CapomacchiaAC.Tobaccosmokexenobioticcompoundappearanceinmothers'milkafterinvoluntarysmokeexposures.I.Nicotineandcotinine.ToxicolLett198315(23):10912.
137. HopkinsonJM,SchanlerRJ,FraleyJKetal.Milkproductionbymothersofprematureinfants:influenceofcigarettesmoking.Pediatrics199290(6):9348.
TherapeuticChoices.CanadianPharmacistsAssociation,2015.Allrightsreserved.
Top Related